Park Avenue Securities LLC Regeneron Pharmaceuticals, Inc. Transaction History

Park Avenue Securities LLC

$8.9 Billion
Q3 2024

A detailed history of Park Avenue Securities LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Park Avenue Securities LLC holds 1,889 shares of REGN stock, worth $1.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,889

Previous 1,755 7.64%

Holding current value

$1.9 Million

Previous $1.85 Million 7.64%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$1024.09 - $1201.76 $137,228 - $161,035	134 Added 7.64%	1,889 $1.99 Million
Q2 2024 Jul 09, 2024	BUY	$883.2 - $1071.19 $74,188 - $89,979	84 Added 5.03%	1,755 $1.85 Million
Q1 2024 Apr 10, 2024	BUY	$902.69 - $993.35 $127,279 - $140,062	141 Added 9.22%	1,671 $1.61 Million
Q4 2023 Jan 10, 2024	BUY	$775.18 - $881.7 $78,293 - $89,051	101 Added 7.07%	1,530 $1.34 Million
Q3 2023 Oct 26, 2023	BUY	$692.45 - $844.37 $989,511 - $1.21 Million	1,429 New	1,429 $1.18 Million
Q4 2022 Jan 24, 2023	BUY	$705.89 - $766.39 $45,176 - $49,048	64 Added 6.11%	1,111 $0
Q3 2022 Nov 01, 2022	BUY	$573.97 - $724.32 $37,308 - $47,080	65 Added 6.62%	1,047 $721,000
Q2 2022 Jul 27, 2022	BUY	$548.35 - $738.84 $66,898 - $90,138	122 Added 14.19%	982 $580,000
Q1 2022 Apr 29, 2022	SELL	$595.12 - $698.43 $462,408 - $542,680	-777 Reduced 47.46%	860 $601,000
Q4 2021 Apr 08, 2022	BUY	$543.48 - $670.97 $515,219 - $636,079	948 Added 137.59%	1,637 $1.03 Million
Q3 2021 Oct 21, 2021	SELL	$574.03 - $680.96 $140,063 - $166,154	-244 Reduced 26.15%	689 $417,000
Q2 2021 Aug 05, 2021	SELL	$472.8 - $558.54 $81,794 - $96,627	-173 Reduced 15.64%	933 $521,000
Q1 2021 Apr 28, 2021	BUY	$446.73 - $548.2 $185,392 - $227,503	415 Added 60.06%	1,106 $523,000
Q4 2020 Jan 20, 2021	BUY	$478.3 - $607.98 $145,881 - $185,433	305 Added 79.02%	691 $334,000
Q3 2020 Nov 03, 2020	BUY	$544.75 - $658.21 $210,273 - $254,069	386 New	386 $216,000

Others Institutions Holding REGN

# of Institutions

1,466

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $108B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Park Avenue Securities LLC with notifications on news.

Account

Park Avenue Securities LLC Regeneron Pharmaceuticals, Inc. Transaction History